Monovalent VHH Manufacturing

• 

  The Advantages of Monovalent VHH Manufacturing

  The process of making Monovalent VHH is started by scientists immunizing a host animal with a particular antigen. They employ cows, llamas or camels as these animals have unique antibodies that can be very helpful in this process. They take the antibodies from blood of the animal after administration of antigen. After getting the antibodies, they break them down to smaller parts and try one of the way VHH Dimeerien valmistus fragment that can bind well to the antigen [22]. A copy of this VHH is then synthesized and amplified via DNA cloning in bacterial or yeast cells.

• 

  Exploring the Process of Monovalent VHH Manufacturing

  The bacteria or yeast cells are then asked to make a whole heap of the VHH piece. After that, the VHH Monomeerituotanto is purified to produce a clean sample that can be used in research or therapy. This refinement process thus guarantees the absence of any impurities with respect to its medical application

• 

  A Look Inside the Laboratory

  At Yaohai's laboratory, the scientists are working quite hard to prepare Monovalent VHH. They wear a lab coat and gloves so everything is cleaned properly and safely. Work with these materials in a sterile environment. They rely on high-grade machinery to monitor every stage of the production process with the proper caution so that there is no hindrance.

Why choose Yaohai Monovalent VHH Manufacturing?

• Ammattitaito ja laaja kokemus

  Yaohai Bio-Pharma is a leading microbiological CDMO. Our focus has been on microbially produced Monovalent VHH Manufacturing and vaccines for human, veterinary and the management of pet health. We have state-of-the-art RD platforms and manufacturing methods which cover the entire procedure starting with microbial strain creation and cell banking, to process and method development to commercial and clinical production and implementation of cutting-edge solutions. Over the years we have gained vast expertise in bio processing using microbial sources. We have successfully delivered over 200 projects across the globe and have assisted our clients with navigating the regulations from the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react rapidly to market requirements and offer a customized CDMO services due to our expertise and knowledge.

• Vankka toimitusketju ja valmistusominaisuudet

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Monovalent VHH Manufacturing manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.

• Räätälöinti, tehokkuus ja kustannustehokkuus

  Yaohai Bio-Pharma is Monovalent VHH Manufacturing in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.

• Laatujärjestelmä ja maailmanlaajuinen säännöstenmukaisuus

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and Monovalent VHH Manufacturing. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

Aiheeseen liittyvät tuoteluokat

• 3-valenttinen VHH-tuotanto
• Anti-HER2 VHH -tuotanto
• Anti-vWF VHH -tuotanto
• Bispesifinen VHH-tuotanto
• Kaksiarvoinen VHH-valmistus
• GMP Anti-CD8 VHH -tuotanto
• GMP Anti-EGFR VHH -tuotanto
• GMP Anti-HER3 VHH -tuotanto
• GMP Anti-MMRCD206 VHH
• GMP Anti-PD-1PD-L1 VHH
• Monovalent VHH Manufacturing

Etkö löydä etsimääsi?
Ota yhteyttä konsulttiimme saadaksesi lisää saatavilla olevia tuotteita.